PP 11
Stevens–Johnson syndrome secondary to rituximab administration in a chronic lymphocytic leukemia patient
Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova
Lido
2744
Vezesque se leu este artigo
1109
Total PDF
1635
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 7 | 80 | 29 | 109 |
| 2025 6 | 73 | 16 | 89 |
| 2025 5 | 73 | 22 | 95 |
| 2025 4 | 67 | 16 | 83 |
| 2025 3 | 66 | 10 | 76 |
| 2025 2 | 47 | 26 | 73 |
| 2025 1 | 36 | 15 | 51 |
| 2024 12 | 43 | 16 | 59 |
| 2024 11 | 56 | 18 | 74 |
| 2024 10 | 52 | 18 | 70 |
| 2024 9 | 45 | 18 | 63 |
| 2024 8 | 86 | 16 | 102 |
| 2024 7 | 39 | 15 | 54 |
| 2024 6 | 44 | 22 | 66 |
| 2024 5 | 46 | 23 | 69 |
| 2024 4 | 37 | 15 | 52 |
| 2024 3 | 43 | 22 | 65 |
| 2024 2 | 34 | 27 | 61 |
| 2024 1 | 29 | 26 | 55 |
| 2023 12 | 32 | 30 | 62 |
| 2023 11 | 41 | 43 | 84 |
| 2023 10 | 27 | 24 | 51 |
| 2023 9 | 36 | 31 | 67 |
| 2023 8 | 21 | 6 | 27 |
| 2023 7 | 26 | 30 | 56 |
| 2023 6 | 23 | 18 | 41 |
| 2023 5 | 21 | 13 | 34 |
| 2023 4 | 15 | 5 | 20 |
| 2023 3 | 12 | 12 | 24 |
| 2023 2 | 10 | 13 | 23 |
| 2023 1 | 12 | 4 | 16 |
| 2022 12 | 10 | 12 | 22 |
| 2022 11 | 23 | 15 | 38 |
| 2022 10 | 20 | 22 | 42 |
| 2022 9 | 15 | 16 | 31 |
| 2022 8 | 16 | 18 | 34 |
| 2022 7 | 10 | 26 | 36 |
| 2022 6 | 11 | 18 | 29 |
| 2022 5 | 11 | 20 | 31 |
| 2022 4 | 11 | 21 | 32 |
| 2022 3 | 12 | 13 | 25 |
| 2022 2 | 13 | 18 | 31 |
| 2021 1 | 8 | 14 | 22 |
| 2021 12 | 10 | 16 | 26 |
| 2021 11 | 13 | 21 | 34 |
| 2021 10 | 10 | 26 | 36 |
| 2021 9 | 11 | 26 | 37 |
| 2021 8 | 18 | 28 | 46 |
| 2021 7 | 15 | 21 | 36 |
| 2021 6 | 11 | 20 | 31 |
| 2021 5 | 33 | 30 | 63 |
| 2021 4 | 22 | 30 | 52 |
| 2021 3 | 24 | 22 | 46 |
| 2021 2 | 7 | 17 | 24 |
| 2020 1 | 11 | 14 | 25 |
| 2020 12 | 12 | 13 | 25 |
| 2020 11 | 6 | 13 | 19 |
Mostrar tudo
